Company name: Celixir
Industry sector: Biotechnology
Business activity: Celixir is an innovative and commercially orientated UK biotechnology and pharmaceutical business at the cutting edge of cell research. It is a leader in regenerative medicine, the next breakthrough medical technology, using adult (non-embryonic) progenitor cells to develop a range of therapies. Since being formed in 2009, it has built a proven, proprietary product development platform and developed a multi-product pipeline of regenerative treatments, with the aim of addressing unmet medical needs across several large addressable markets.
Why is IP important to you? IP is important to us because we are an innovative technology company.
Does IP underpin your competitive advantage? IP is essential to maintain our competitive advantage because it prevents third parties from using our technology and know how.